Millipore Sigma Vibrant Logo

CC4075 Human Plasminogen activator inhibitor-1, recombinant

Human Plasminogen activator inhibitor-1, recombinant: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。
Key Applications: Activity Assay, Inhibits Activity/Function UniProt Number: P05121 Entrez Gene Number: NM_000602
View This Product on Sigma-Aldrich
CC4075
50 µg  
価格を検索中…
価格が見つかりません
Minimum Quantity needs to be mulitiple of
Maximum Quantity is
弊社照会 詳細を表示　
値引
()
 
—
弊社照会
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

       

      お問合せください

      概要

      Replacement Information
      Description
      Catalogue NumberCC4075
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionHuman Plasminogen activator inhibitor-1, recombinant
      OverviewThe sequence corresponding to amino acids 24 to 402 of human PAI-1 (mature form) tagged with 6xHis on the carboxy-terminal was expressed in E. Coli.
      Alternate Names
      • PAI 1
      • SERPINE1
      • PAI1
      Background InformationPlasminogen activator inhibitor-1 (PAI-1) is a member of the serine protease inhibitor (serpin) superfamily and a central regulatory protein in the blood coagulation system. PAI-1 is unique among serpins in exhibiting distinct active and inactive (latent) conformations in vivo. Human PAI-1 is a single-chain glycoprotein with a molecular weight of 43 kDa. This inhibitor acts as "bait" for tissue-type and urokinase-type plasminogen activators (tPA and uPA) and protein C. Its rapid interaction with tPA may function as a major control point in the regulation of fibrinolysis. The highly mobile reactive-center loop (RCL) is thought to account for both the rapid inhibiton of plasminogen activators, and the rapid and spontaneous transition of the unstable, active form of PAI-1 into the stable, inactive conformation (t1/2 at 37oC, 2 hours). The inactive form can be partially reactivated by denaturants such as urea, guanidine hydrochloride or SDS. High concentrations of PAI-1 have been associated with human thromboembolic disease. PAI-1 activity may limit the extent of tumor metastasis, since uPA activity is a major contributory factor promoting dissolution of tumor matrix and basement membrane.
      References
      Product Information
      PresentationLiquid. In 150 mM Na2HPO4, pH 6.6, 500 mM NaCl, 2 mM Glutathione, and 0.01% Tween-80.
      Quality LevelMQ100
      Applications
      Key Applications
      • Activity Assay
      • Inhibits Activity/Function
      Biological Information
      Purity>/=98%, as determined by SDS-PAGE gel electrophores. Endotoxin level: < 1EU/microgram.
      Specific ActivityBy uPA activity assay, the recombinant PAI-1 contains a mixture of the active and latent forms, with > 45% of active form. To fully activate the latent PAI-1, the PAI-1 must be incubated in Activation Buffer (2X Activation Buffer: 8 M Guanidine HCl, 40 mM Sodium Acetate, pH 5.6, 400 mM NaCl, 0.2% Tween 20) for 15 to 30 minutes (Sancho, 1994). The recombinant PAI-1 is able to bind to uPA resulting in a SDS-stable complex.
      Entrez Gene Number
      Entrez Gene SummaryPlasminogen activator inhibitor-1 (PAI-1) is the primary, fast-acting inhibitor of plasminogen activators. It is often bound to vitronectin, an abundant component of the extracellular matrix in many tissues. Protease nexin-1 is a potent serpin able to inhibit thrombin, plasmin, and plasminogen activators. PAI-1 and nexin-1 are members of the serpin superfamily and represent clade E. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones.
      Gene Symbol
      • PAI
      • PAI1
      • PAI-1
      • PLANH1
      • SERPINE1
      UniProt Number
      UniProt SummaryFUNCTION: This inhibitor acts as 'bait' for tissue plasminogen activator, urokinase, and protein C. Its rapid interaction with TPA may function as a major control point in the regulation of fibrinolysis.
      SUBUNIT STRUCTURE: Interacts with VTN. Binds LRP1B; binding is followed by internalization and degradation.
      SUBCELLULAR LOCATION: Secreted.
      TISSUE SPECIFICITY: Found in plasma and platelets and in endothelial, hepatoma and fibrosarcoma cells.
      PTMs: Inactivated by proteolytic attack of the urokinase-type (u-PA) and the tissue-type (TPA), cleaving the 369-Arg-|-Met-370 bond.
      DISEASE: Defects in SERPINE1 are the cause of plasminogen activator inhibitor-1 deficiency (PAI-1 deficiency) [MIM:173360]. This deficiency is characterized by abnormal bleeding due to SERPINE1 defect in the plasma.
      High concentrations of SERPINE1 have been associated with thrombophilia [MIM:188050]; an autosomal dominant disorder in which affected individuals are prone to develop serious spontaneous thrombosis.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStore at -80ºC. Thaw on ice and freeze aliquots at -80ºC for longer storage. This product is stable for at least 2 years as supplied. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size50 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      CC4075 04053252620546

      Documentation

      Protocols

      Title
      MMP Activation Chart

      Human Plasminogen activator inhibitor-1, recombinant (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      Human Plasminogen activator inhibitor-1, recombinant 試験成績書（CoA）

      タイトルロット番号
      HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] RECOMBINANT PROTEIN - 2318098 2318098
      HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] RECOMBINANT PROTEIN - 2433410 2433410
      HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] - 3173548 3173548
      HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] - 3559004 3559004
      HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] - 3819959 3819959
      HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] - 3905457 3905457
      HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] - 3922568 3922568
      HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] - 4117354 4117354
      HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] -2601679 2601679
      HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] -2766482 2766482
      Show more

      参考資料

      参考資料の概要Pub Med ID
      Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center.
      Sherman, P M, et al.
      J. Biol. Chem., 267: 7588-95 (1992)  1992

      概要を表示する       		1559996 1559996